Correlation Between Pfizer and Innovator Equity
Can any of the company-specific risk be diversified away by investing in both Pfizer and Innovator Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Innovator Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Innovator Equity Power, you can compare the effects of market volatilities on Pfizer and Innovator Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Innovator Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Innovator Equity.
Diversification Opportunities for Pfizer and Innovator Equity
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pfizer and Innovator is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Innovator Equity Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Equity Power and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Innovator Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Equity Power has no effect on the direction of Pfizer i.e., Pfizer and Innovator Equity go up and down completely randomly.
Pair Corralation between Pfizer and Innovator Equity
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Innovator Equity. In addition to that, Pfizer is 3.46 times more volatile than Innovator Equity Power. It trades about -0.05 of its total potential returns per unit of risk. Innovator Equity Power is currently generating about 0.13 per unit of volatility. If you would invest 3,602 in Innovator Equity Power on August 24, 2024 and sell it today you would earn a total of 243.00 from holding Innovator Equity Power or generate 6.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Innovator Equity Power
Performance |
| Timeline |
| Pfizer Inc |
| Innovator Equity Power |
Pfizer and Innovator Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Innovator Equity
The main advantage of trading using opposite Pfizer and Innovator Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Innovator Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Equity will offset losses from the drop in Innovator Equity's long position.| Pfizer vs. Johnson Johnson | Pfizer vs. Small Cap Core | Pfizer vs. Freedom Holding Corp | Pfizer vs. Gfl Environmental Holdings |
| Innovator Equity vs. Innovator ETFs Trust | Innovator Equity vs. First Trust Cboe | Innovator Equity vs. FT Cboe Vest | Innovator Equity vs. Innovator SP 500 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |